800mg CBC-Rich Tincture | Anxiety & Stress Support | Zero THC

The Anxiety & Stress Cannabinoid. Scientifically Targeted.

Cannabichromene (CBC) is one of the six major phytocannabinoids — and one of the most underutilized. While CBD dominates the market, CBC operates through a distinct receptor profile that makes it particularly relevant for anxiety, stress, and mood support: TRPV1 and TRPA1 receptor activation, and anandamide reuptake inhibition — the mechanism that preserves your body's own "bliss molecule."

cbdDR's 800mg CBC-Rich Tincture delivers 650mg CBC as the primary active cannabinoid per bottle — a concentration not available in most broad spectrum products, where CBC appears only in trace amounts. Formulated in-house by botanical scientist Matthew Scott since 2014. Not white-labeled. Standardized. Third-party tested every batch.

Formulation Specifications

• Total Cannabinoids: 800mg per 30ml bottle
• Primary Cannabinoid: CBC (Cannabichromene) — 650mg
• Supporting Cannabinoids: CBD — 50mg | CBG — 50mg | CBN — 50mg
• Serving Size: 1ml sublingual
• Servings Per Bottle: ~30
• Cannabinoids Per Serving: ~27mg
• THC: Zero — non-detected on every batch COA
• Carrier: MCT Oil (coconut-derived)
• Administration: Sublingual (under tongue, hold 60–90 seconds)

How CBC Works: The Science

CBC's mechanisms are distinct from CBD and CBG — which is why it cannot be replaced by simply taking more CBD:

• TRPV1 receptor activation and desensitization — CBC activates transient receptor potential vanilloid 1 channels involved in pain and inflammatory signaling, then causes receptor desensitization, reducing responsiveness to subsequent stress signals
• TRPA1 receptor activation — CBC engages TRPA1 channels involved in neurogenic inflammation and sensory pain pathways
• Anandamide reuptake inhibition — CBC inhibits cellular reuptake of anandamide (the endogenous "bliss" cannabinoid), increasing its extracellular concentration and prolonging its anxiolytic activity — a mechanism analogous to how SSRIs work for serotonin

A 2010 study by El-Alfy et al. in Pharmacology Biochemistry and Behavior demonstrated significant antidepressant-like activity for CBC in preclinical models. A 2013 study by Shinjyo and Di Marzo found CBC positively influenced neural stem progenitor cell viability — suggesting potential neurogenesis support relevant to long-term mood wellness.

The Entourage Effect: Why Supporting Cannabinoids Matter

The 50mg each of CBD, CBG, and CBN in this formulation are not filler — they are strategic. CBD contributes NF-κB inhibition and adenosine potentiation. CBG contributes CB2 receptor engagement. CBN contributes CB1 partial agonism for calming support. Together with CBC's unique TRPV1/TRPA1/anandamide mechanisms, this formulation delivers multi-pathway endocannabinoid system modulation that no single cannabinoid can replicate.

Available Flavors

• Natural (unflavored)
• Chocolate Mint
• Mint
• Milk Chocolate
• Citrus

Suggested Use

Place 1ml under tongue using the dropper. Hold for 60–90 seconds. Swallow. Use once daily or as needed for stress and anxiety support. Best taken consistently for 2–4 weeks to assess full effect as the endocannabinoid system responds to regular cannabinoid input.

Third-Party Testing

Every batch tested by an ISO/IEC 17025-accredited independent laboratory. Full-panel COA: potency, heavy metals, pesticides, residual solvents, microbials. Results published batch-by-batch in our Batch Database.

Quality Assurance

• ✅ 650mg CBC primary — standardized, not trace amounts
• ✅ Formulated in-house by Matthew Scott, Botanical Scientist
• ✅ Zero THC — verified by independent laboratory testing
• ✅ ISO/IEC 17025-accredited third-party testing every batch
• ✅ No white label — every formulation is our own

View Batch Database →  |  CBC Science Page →  |  CBC Science Article →

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare provider before use.